Allogeneic T Cell Therapies

The current landscape of allogeneic CAR T-cell therapies

Allogeneic T cell therapies

The Antibody Society

Cellectis Allogeneic CAR-T Cells

Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.

Adaptimmune Therapeutics

What is an Allogeneic CAR T Cell?

HealthTree University for Multiple Myeloma

CAR T-Cell Therapy: How Does It Work?

Dana-Farber Cancer Institute

Advances in allogeneic CAR-T therapy in lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

PBCAR0191, an allogeneic CAR T-cell therapy, in B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Pros and cons of autologous and allogeneic CAR-Ts

VJHemOnc – Video Journal of Hematology & HemOnc

Focusing on allogeneic CAR T-cell therapies for myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Neelapu on Potential Advantages of Allogeneic CAR T-Cell Therapy in Lymphoma

Advances in allogeneic γδ T cells

ADI-001: anti-CD20 CAR-engineered allogeneic γδ T cells in adults with B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

The promise of allogeneic T and NK cells in immuno-oncology | Neil Sheppard | Stem Cell Jungle

In the Stem Cell Jungle

Allogeneic CAR T-Cell Approaches for NHL

The promise of allogeneic CAR-T cell products for the treatment of hematological malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Update on CAR T-Cell Therapy | LRF Webinars

Lymphoma Research Foundation

CAR T-Cell Therapy Innovations

Autologous vs Allogeneic Cell Therapy

Transposon-manipulated allogeneic CAR-T therapy for B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc